Filing Details
- Accession Number:
- 0001209191-22-014778
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-02 16:38:59
- Reporting Period:
- 2022-02-28
- Accepted Time:
- 2022-03-02 16:38:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1674930 | Fulgent Genetics Inc. | FLGT | Services-Medical Laboratories (8071) | 812621304 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1819718 | Jian Xie | C/O Fulgent Genetics, Inc. 4978 Santa Anita Ave., Ste 205 Temple City CA 91780 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-28 | 9,000 | $0.00 | 306,234 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-02-28 | 32,000 | $0.00 | 338,234 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-03-01 | 622 | $63.30 | 337,612 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
- Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
- The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person onFebruary 27, 2019.
- The shares were sold in multiple transactions at prices ranging from $62.3100 to $64.3650, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
